Clinical Trials · NCT05896293
Kisspeptin Administration Subcutaneously to Patients With IHH
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Stephanie B. Seminara, MD
- Enrollment
- 36
- Start date
- Feb 2023
- Locations
- 1 site, United States
- Primary endpoint
- Average change in luteinizing hormone (LH) pulse amplitude